IonQ, Inc. (IONQ) Financial Statements
IonQ, Inc. (IONQ) reported trailing twelve-month revenue of $246.5M (up 370.6% year on year) and net income of -$1.4B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$483.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IONQIonQ, Inc.Follow IONQ — free
—
Price chart with a free account
- Market cap
- 11.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.01 | 0.02 | 0.04 | 0.13 | 0.25 | |
| Gross profit | 0.00 | 0.01 | 0.01 | 0.02 | 0.05 | 0.07 | |
| Research & development | 0.02 | 0.04 | 0.09 | 0.14 | 0.31 | 0.45 | |
| Operating income | -0.04 | -0.09 | -0.16 | -0.23 | -0.63 | -1.01 | |
| Pre-tax income | -0.11 | -0.05 | -0.16 | -0.33 | -0.56 | -1.41 | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | -0.04 | |
| Net income | -0.11 | -0.05 | -0.16 | -0.33 | -0.51 | -1.36 | |
| Diluted EPS ($) | -0.77 | -0.25 | -0.78 | -1.56 | -1.82 | -3.81 | |
| Diluted shares (bn) | — | 0.198 | 0.203 | 0.213 | 0.280 | — |
USD billions · SEC XBRL
IonQ, Inc. — questions
- What is IonQ, Inc.'s revenue?
- $246.5M over the twelve months to 2026-06-30, up 370.6% year on year, from its 10-Q and 10-K filings.
- What is IonQ, Inc.'s net income?
- -$1.4B over the twelve months to 2026-06-30.
- What is IonQ, Inc.'s free cash flow?
- -$483.9M over the twelve months to 2026-06-30.
- What are IonQ, Inc.'s diluted earnings per share?
- $-3.81 over the twelve months to 2026-06-30.
Every figure on this page comes from IonQ, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.